glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Salidroside sensitizes Triple-negative breast cancer
Salidroside sensitizes Triple negative breast cancer to ferroptosis by SCD1 mediated lipogenesis and NCOA4 mediated ferritinophagy ScienceDirect Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




